• D. Boral Capital Reaffirms Buy Rating for Context Therapeutics (NASDAQ:CNTX)

    Source: Buzz FX / 15 Jan 2025 07:41:15   America/New_York


    D. Boral Capital Reaffirms Buy Rating for Context Therapeutics (NASDAQ:CNTX) Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Context Therapeutics ( NASDAQ:CNTX - Get Free Report ) 's stock had its "buy" rating reaffir
    Read more...
Share on,